[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [BNTX](/topic/bntx) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "GIPR showing real strength lately; rising income lower yields and solid management execution could fuel a $2+ push soon. 🔥 $SYRE $DENLI $XENE $RIOT $RNA $ACLX $BIO $BHVN $AXSM $BNTX $EXEL $REGN $VRTX $BBIO $DCTH $QURE $RCKT $VKTX $XERS $ADMA $KRYS $SMMT $CPRX" [X Link](https://x.com/A1PHAEDGE/status/1981453407874334766) [@A1PHAEDGE](/creator/x/A1PHAEDGE) 2025-10-23T20:11Z XXX followers, XX engagements "Moderna vs. BioNTech: Whos Really Winning the Post-COVID Race Ratings: BioNTech ( $BNTX): Buy stronger balance sheet superior partnerships and long-term oncology optionality. Moderna ( $MRNA): Buy undervalued short-term rebound potential but higher execution risk. After years of pandemic-fueled profits the mRNA vaccine giants Moderna $MRNA and BioNTech $BNTX have entered a new chapter. The COVID gold rush is over and investors are finally asking the harder question: whos better positioned to win in a world thats moved on from pandemic-era shots Ive covered several of these head-to-head" [X Link](https://x.com/hataf_capital/status/1980594311646310560) [@hataf_capital](/creator/x/hataf_capital) 2025-10-21T11:17Z 3076 followers, XXX engagements "PD-1 x VEGF news: Shanghai Junshi says it's got FDA approval to start a US ph2/3 trial of JS207 head-to-head vs Opdivo in neoadjuvant NSCLC $SMMT $TIL $BNTX" [X Link](https://x.com/JacobPlieth/status/1978809705532203166) [@JacobPlieth](/creator/x/JacobPlieth) 2025-10-16T13:06Z 30.9K followers, 7559 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"GIPR showing real strength lately; rising income lower yields and solid management execution could fuel a $2+ push soon. 🔥 $SYRE $DENLI $XENE $RIOT $RNA $ACLX $BIO $BHVN $AXSM $BNTX $EXEL $REGN $VRTX $BBIO $DCTH $QURE $RCKT $VKTX $XERS $ADMA $KRYS $SMMT $CPRX"
X Link @A1PHAEDGE 2025-10-23T20:11Z XXX followers, XX engagements
"Moderna vs. BioNTech: Whos Really Winning the Post-COVID Race Ratings: BioNTech ( $BNTX): Buy stronger balance sheet superior partnerships and long-term oncology optionality. Moderna ( $MRNA): Buy undervalued short-term rebound potential but higher execution risk. After years of pandemic-fueled profits the mRNA vaccine giants Moderna $MRNA and BioNTech $BNTX have entered a new chapter. The COVID gold rush is over and investors are finally asking the harder question: whos better positioned to win in a world thats moved on from pandemic-era shots Ive covered several of these head-to-head"
X Link @hataf_capital 2025-10-21T11:17Z 3076 followers, XXX engagements
"PD-1 x VEGF news: Shanghai Junshi says it's got FDA approval to start a US ph2/3 trial of JS207 head-to-head vs Opdivo in neoadjuvant NSCLC $SMMT $TIL $BNTX"
X Link @JacobPlieth 2025-10-16T13:06Z 30.9K followers, 7559 engagements
/topic/bntx/posts